$0.289
+0.003 (+1.01%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GTBP por análisis de gráficos similares
Alphio's GTBP stock price prediction model matches the current GT Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.29 (-1.25%). The 1-week path is $0.29 (-0.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de GT Biopharma Inc?
GT Biopharma Inc is currently not a strong buy due to its ongoing financial losses and declining stock performance, despite a recent positive trend. The stock closed at $0.30, with a year-to-date decline of 63.28%. The RSI is at 53.044, indicating a neutral momentum, while the forward P/E ratio is 17.331, suggesting potential for future earnings but also a risk given the company’s current losses. The main risk is the significant net loss of $28.4 million reported for FY2025, which raises concerns about profitability and investor confidence.
GTBP cerró en $0.29 el Tuesday, tras subir +1.01%
GT Biopharma Inc (GTBP) last closed at $0.2889, gaining +1.01%. These facts feed the 1-day and 1-week GTBP price prediction above.
Factores de la previsión
Los factores de la previsión de GT Biopharma Inc (GTBP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GTBP, ordenadas por similitud.
Análisis de estacionalidad de GTBP
Historically the probability of a positive September return for GTBP is 0.00%. June offers the highest probability of a positive month at 16.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GTBP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $2.42 | $2.49 | $2.64 | +761.01% |
| Oct 2026 | $2.21 | $2.25 | $2.32 | +678.93% |
| Nov 2026 | $1.97 | $2.17 | $2.56 | +652.64% |
| Dec 2026 | $2.03 | $2.26 | $2.28 | +683.07% |
En 2026, se proyecta que GT Biopharma Inc (GTBP) oscile entre $1.97 y $2.64.
Previsión mensual de GT Biopharma Inc para 2026
En Sep de 2026, se proyecta que GT Biopharma Inc promedie $2.49, con un mínimo de $2.42 y un máximo de $2.64.
En Oct de 2026, se proyecta que GT Biopharma Inc promedie $2.25, con un mínimo de $2.21 y un máximo de $2.32.
En Nov de 2026, se proyecta que GT Biopharma Inc promedie $2.17, con un mínimo de $1.97 y un máximo de $2.56.
En Dec de 2026, se proyecta que GT Biopharma Inc promedie $2.26, con un mínimo de $2.03 y un máximo de $2.28.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.